Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma
Guangxi Medical University
Guangxi Medical University
Incyte Corporation
Groupe Oncologie Radiotherapie Tete et Cou
Merck Sharp & Dohme LLC
GERCOR - Multidisciplinary Oncology Cooperative Group
Merck Sharp & Dohme LLC
University of Chicago
University of Chicago
City of Hope Medical Center
Hospital of Stomatology, Wuhan University
Institute of Oncology Ljubljana
University of Chicago
University of Chicago
University Medical Center Groningen
Austrian South Oncology Group
University of Chicago
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Presage Biosciences
Bristol-Myers Squibb
National Cancer Institute (NCI)
Assistance Publique Hopitaux De Marseille
Sun Yat-sen University
Children's Oncology Group
Groupe Oncologie Radiotherapie Tete et Cou
Groupe Oncologie Radiotherapie Tete et Cou
Arbeitsgemeinschaft medikamentoese Tumortherapie
Merck KGaA, Darmstadt, Germany
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Glycotope GmbH
Massachusetts General Hospital
AstraZeneca
Sun Yat-sen University
UNICANCER
UNICANCER
Washington University School of Medicine
Washington University School of Medicine
AstraZeneca
Case Comprehensive Cancer Center
Wake Forest University Health Sciences
Fudan University
Celgene
University of Chicago
Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company
Hong Kong Nasopharyngeal Cancer Study Group Limited
NanoCarrier Co., Ltd.
Groupe Oncologie Radiotherapie Tete et Cou
Amgen
European Organisation for Research and Treatment of Cancer - EORTC